MelissaAnneTaylorMDMPH

PubMed

• 2 citations
  Optimizing the duration of trastuzumab: A fresh perspective
  Melissa A. Taylor, Kristina F Byers, Jane L. Meisel> ;Oncology. 2020 Aug 10
• 3 citations
  Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population--A SEER-based analysis from 2000 to 2016.
  Melissa A. Taylor, J. Switchenko, William A. Stokes, Mihir R. Patel, Mark W. McDonald, Conor E. Steuer, Ashley H. Aiken, Jonathan J. Beitler, Dong M. Shin, Nabil F. Saba> ;Cancer Medicine. 2021 Jul 20
• 4 citations
  Cancer of the Paranasal Sinuses
  Melissa A. Taylor, Nabil F. Saba> ;Hematology/oncology Clinics of North America. 2021 Jul 2
• 1 citations
  Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy.
  Melissa A. Taylor, Mehrdad Alemozaffar, Viraj A. Master, Martin G. Sanda, Christopher P. Filson> ;Clinical Genitourinary Cancer. 2019 Jun 1
• Join now to see all

Journal Articles

• Rise in Node-Positive Prostate Cancer Incidence in Context of Evolving Use and Extent of Pelvic Lymphadenectomy  
  Taylor MA, Alemozaffar M, Master VA, Sanda MG, Filson CP., Clinical Genitourinary Cancer, 1/26/2019
• Lymphadenectomy for High-Risk Prostate Cancer Patients: What Is Going on in Georgia?  
  Mark Henry, MD, Melissa Taylor, MD, Frances Kim, MPH, John G. Pattaras, MD, FACS, Mehrdad Alemozaffar, MD, Viraj Master, MD, PhD, Christopher P. Filson, MD, MS, Journal of the American College of Surgeons, 10/2018

Abstracts/Posters

• Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population: A SEER based analysis from 2000-2016.
  Taylor MA, Patel M, Switchenko JM, McDonald MW, Steuer CE, Beitler JJ, Shin, DM, Saba NF, Journal of Clinical Oncology, 5/13/2020